Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy.[1]
Silverberg MS (2006). "OCTNs: will the real IBD5 gene please stand up?". World J. Gastroenterol. 12 (23): 3678–3681. PMID16773684.
Matsuishi T, Hirata K, Terasawa K, et al. (1985). "Successful carnitine treatment in two siblings having lipid storage myopathy with hypertrophic cardiomyopathy". Neuropediatrics. 16 (1): 6–12. doi:10.1055/s-2008-1052536. PMID3974805.
Wu X, Prasad PD, Leibach FH, Ganapathy V (1998). "cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family". Biochem. Biophys. Res. Commun. 246 (3): 589–95. doi:10.1006/bbrc.1998.8669. PMID9618255.
Tamai I, Ohashi R, Nezu J, et al. (1998). "Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2". J. Biol. Chem. 273 (32): 20378–82. doi:10.1074/jbc.273.32.20378. PMID9685390.
Nezu J, Tamai I, Oku A, et al. (1999). "Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter". Nat. Genet. 21 (1): 91–4. doi:10.1038/5030. PMID9916797.
Tang NL, Ganapathy V, Wu X, et al. (1999). "Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency". Hum. Mol. Genet. 8 (4): 655–60. doi:10.1093/hmg/8.4.655. PMID10072434.
Burwinkel B, Kreuder J, Schweitzer S, et al. (1999). "Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality". Biochem. Biophys. Res. Commun. 261 (2): 484–7. doi:10.1006/bbrc.1999.1060. PMID10425211.
Wu X, Huang W, Prasad PD, et al. (1999). "Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter". J. Pharmacol. Exp. Ther. 290 (3): 1482–1492. PMID10454528.
Vaz FM, Scholte HR, Ruiter J, et al. (1999). "Identification of two novel mutations in OCTN2 of three patients with systemic carnitine deficiency". Hum. Genet. 105 (1–2): 157–61. doi:10.1007/s004390051079. PMID10480371.
Koizumi A, Nozaki J, Ohura T, et al. (1999). "Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency". Hum. Mol. Genet. 8 (12): 2247–2254. doi:10.1093/hmg/8.12.2247. PMID10545605.
Seth P, Wu X, Huang W, et al. (1999). "Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function". J. Biol. Chem. 274 (47): 33388–92. doi:10.1074/jbc.274.47.33388. PMID10559218.
Ohashi R, Tamai I, Inano A, et al. (2002). "Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein". J. Pharmacol. Exp. Ther. 302 (3): 1286–1294. doi:10.1124/jpet.102.036004. PMID12183691.
Rahbeeni Z, Vaz FM, Al-Hussein K, et al. (2003). "Identification of two novel mutations in OCTN2 from two Saudi patients with systemic carnitine deficiency". J. Inherit. Metab. Dis. 25 (5): 363–9. doi:10.1023/A:1020143632011. PMID12408185.
Elimrani I, Lahjouji K, Seidman E, et al. (2003). "Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells". Am. J. Physiol. Gastrointest. Liver Physiol. 284 (5): G863–71. doi:10.1152/ajpgi.00220.2002. PMID12684216.
Karlic H, Lohninger A, Laschan C, et al. (2004). "Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes". J. Mol. Med. 81 (7): 435–42. doi:10.1007/s00109-003-0447-6. PMID12802501.
Amat di San Filippo C, Wang Y, Longo N (2004). "Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency". J. Biol. Chem. 278 (48): 47776–84. doi:10.1074/jbc.M307911200. PMID14506273.